China has more than 200 million hypertensive patients, according to Ma Xiaowei, an official at the National Health and Family Planning Commission of China.
Today, National Health and Family Planning Commission (“NHFPC”) issued Circular on Further Enhancing the Management of Drugs use at Grassroots Medical Institutions, which explicitly stated that new drugs are not encouraged to enlist into Essential Drug List (“EDL”)
Following is a brief summary and prospect of these new progresses.
“jk-05”, the new drug designated to treat Ebola has passed the evaluation by health experts at the People’s Liberation Army General Medical Department.
Recently, many provinces including Sichuan and Jiangxi have begun a new round of drug tendering.
The interim results of the major listed pharmaceutical companies showed that the whole pharmaceutical industry has maintained a steady and slower year-on-year growth. In the first half of 2014